Racial disparities in patients with TP53 mutated acute myeloid leukemia.

被引：0
|
作者：
Badar, Talha
Litzow, Mark Robert
Shallis, Rory
Stahl, Maximilian
Bewersdorf, Jan Philipp
Saliba, Antoine N.
Correia, Guilherme Sacchi De Camargo
Patel, Anand Ashwin
Abaza, Yasmin
Murthy, Guru Subramanian Guru
Duvall, Adam
Burkart, Madelyn
Al-Kali, Aref
Palmisiano, Neil
Dinner, Shira
Goldberg, Aaron David
Atallah, Ehab L.
机构：
[1] Mayo Clin, Jacksonville, FL USA
[2] Mayo Clin, Div Hematol, Rochester, MN USA
[3] Yale Sch Med, New Haven, CT USA
[4] Mem Sloan Kettering Canc Ctr, New York, NY USA
[5] Yale Univ Sch Med, New Haven, CT USA
[6] Mt Sanai Hosp, New York, NY USA
[7] Univ Chicago, Chicago, IL USA
[8] Northwestern Mem Hosp, Chicago, IL USA
[9] Med Coll Wisconsin, Div Hematol Oncol, Milwaukee, WI USA
[10] Univ Chicago Med, Chicago, IL USA
[11] Thomas Jefferson Univ Hosp, Philadelphia, PA USA
[12] Med Coll Wisconsin, Milwaukee, WI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19007
引用
收藏
页码：E19007 / E19007
页数：1
相关论文
共 50 条
  • [1] TP53 mutated acute myeloid leukemia
    Sill, H.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 257 - 257
  • [2] Impact of TP53 Mutated Subclones in Acute Myeloid Leukemia
    Pabst, Gabriel
    Prochazka, Katharina
    Pregartner, Gudrun
    Rucker, Frank G.
    Heitzer, Ellen
    Woelfler, Albert
    Zebisch, Armin
    Berghold, Andrea
    Dohner, Konstanze
    Sill, Heinz
    BLOOD, 2018, 132
  • [3] Leukemia Physician's Perspective on Transplant in Patients with TP53 Mutated Acute Myeloid Leukemia
    Uanegas, Yenny Alejandra Moreno
    El Khatib, Suhaib Younis Mohamed
    Hisrich, Brooke
    Coltoff, Alexander
    Shallis, Rory M.
    Patel, Anand Ashwin
    Bewersdorf, Jan Philipp
    Oh, Timothy S.
    Abaza, Yasmin
    Foucar, Charles
    Goldberg, Aaron D.
    Duvall, Adam S.
    Atallah, Ehab L.
    Litzow, Mark R.
    Badar, Talha
    BLOOD, 2024, 144 : 1487 - 1488
  • [4] Personalized Medicine for TP53 Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia
    Cluzeau, Thomas
    Loschi, Michael
    Fenaux, Pierre
    Komrokji, Rami
    Sallman, David A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (18)
  • [5] TP53 Action and the Consequences of TP53 Mutation in Acute Myeloid Leukemia
    Lowe, Scott W.
    BLOOD, 2019, 134
  • [6] Acute erythroid leukemia or acute myeloid leukemia with mutated TP53? The battle of phenotype versus genotype
    Parisi, Xenia
    Loghavi, Sanam
    BLOOD, 2025, 145 (07) : 784 - 784
  • [7] What Are the Prospects for Treating TP53 Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia?
    Wang, Chen
    Sallman, David A.
    CANCER JOURNAL, 2022, 28 (01) : 51 - 61
  • [8] Distinct pattern of alterations in tp53 mutated and wild type acute myeloid leukemia (AML) patients
    Ferrari, Anna
    Fonzi, Eugenio
    Fontana, Maria Chiara
    Di Rora, Andrea Ghelli Luserna
    Manfrini, Marco
    Padella, Antonella
    Baldazzi, Carmen
    Papayannidis, Cristina
    Marconi, Giovanni
    Paolini, Stefania
    Guadagnuolo, Viviana
    Perricone, Margherita
    Robustelli, Valentina
    Imbrogno, Enrica
    Franchini, Eugenia
    Venturi, Claudia
    Zuffa, Elisa
    Abbenante, Maria Chiara
    Simonetti, Giorgia
    Testoni, Nicoletta
    Ottaviani, Emanuela
    Giovanni, Martinelli
    CANCER RESEARCH, 2017, 77
  • [9] Clonal expansion of TP53 mutated cells is associated with chemoresistance in acute myeloid leukemia
    Yan, Bowen
    Qiu, Yi
    CANCER RESEARCH, 2019, 79 (13)
  • [10] Comparative Assessment of p53 Immunohistochemistry and TP53 Molecular Analysis for Prediction in Diagnosis of TP53 Mutated Acute Myeloid Leukemia
    Matsumoto, Nana
    Wilton, Katelynn
    Pinkus, Geraldine
    Lovitch, Scott
    LABORATORY INVESTIGATION, 2023, 103 (03) : S1192 - S1193
12345